Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Medical Journal ; (24): 542-549, 2013.
Article in English | WPRIM | ID: wpr-342547

ABSTRACT

<p><b>OBJECTIVE</b>To review the mechanisms and current clinical application of pharmacological interventions for phantom limb pain.</p><p><b>DATA SOURCES</b>Both Chinese and English language literatures were searched using MEDLINE (1982 - 2011), Pubmed (1982 - 2011) and the Index of Chinese Language Literature (1982 - 2011).</p><p><b>STUDY SELECTION</b>Data from published articles about pharmacological management of phantom limb pain in recent domestic and foreign literature were selected. Data extraction Data were mainly extracted from 96 articles which are listed in the reference section of this review.</p><p><b>RESULTS</b>By reviewing the mechanisms and current clinical application of pharmacological interventions for phantom limb pain, including anticonvulsants, antidepressants, local anaesthetics, N-methyl-D-aspartate receptor antagonists, non-steroidal anti-inflammatory drugs, tramadol, opioids, calcitonin, capsaicin, beta-adrenergic blockers, clonidine, muscle relaxants, and emerging drugs, we examined the efficacy and safety of these medications, outlined the limitations and future directions.</p><p><b>CONCLUSIONS</b>Although there is lack of evidence-based consensus guidelines for the pharmacological management of phantom limb pain, we recommend tricyclic antidepressants, gabapentin, tramadol, opioids, local anaesthetics and N-methyl-D-aspartate receptor antagonists as the rational options for the treatment of phantom limb pain.</p>


Subject(s)
Humans , Analgesics , Therapeutic Uses , Analgesics, Opioid , Therapeutic Uses , Anticonvulsants , Therapeutic Uses , Antidepressive Agents , Therapeutic Uses , Phantom Limb , Drug Therapy , Tramadol , Therapeutic Uses
2.
Chinese Journal of Oncology ; (12): 178-180, 2003.
Article in Chinese | WPRIM | ID: wpr-347465

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the complications and treatment results of intraoperative radiotherapy (IORT) for esophageal carcinoma.</p><p><b>METHODS</b>Sixty patients with thoracic esophageal carcinoma underwent esophagectomy through right thoractomy, 30 patients of whom received IORT of 15 - 25 Gy.</p><p><b>RESULTS</b>In patients who underwent IORT, 2 cases of pneumonitis, 1 case of anastomotic leak and 1 case of incisional wound infection were found. In patients underwent surgery only, 1 case of thoracic empyema and 1 case of anastomotic leak were found. All the complications ultimately healed. There was no operative mortality. During the follow-up of 3 years, in patients who underwent IORT, 2 of 3 died of radiation pneumonitis 24 and 26 months after IORT with one complicated with bronchoesophageal fistula. One of 3 died of multiple lung metastases. The 3-year survival rate was 88.0% (22/25) in IORT group and 76.0% (19/25) in surgery only group.</p><p><b>CONCLUSION</b>Intraoperative radiotherapy can reduce locoregional recurrence if performed to thoracic esophageal carcinoma patients without surgical contraindication or distant metastasis. Radiation pneumonitis, a common complication difficult to manage, implies a poor prognosis and, consequently, the lung and bronchus should be protected from the radiation.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Combined Modality Therapy , Esophageal Neoplasms , Mortality , Therapeutics , Neoplasm Recurrence, Local , Radiotherapy Dosage
SELECTION OF CITATIONS
SEARCH DETAIL